AU2003215004A8 - Msrebps as modifiers of the srebp pathway and methods of use - Google Patents

Msrebps as modifiers of the srebp pathway and methods of use

Info

Publication number
AU2003215004A8
AU2003215004A8 AU2003215004A AU2003215004A AU2003215004A8 AU 2003215004 A8 AU2003215004 A8 AU 2003215004A8 AU 2003215004 A AU2003215004 A AU 2003215004A AU 2003215004 A AU2003215004 A AU 2003215004A AU 2003215004 A8 AU2003215004 A8 AU 2003215004A8
Authority
AU
Australia
Prior art keywords
msrebps
modifiers
methods
srebp pathway
srebp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003215004A
Other versions
AU2003215004A1 (en
Inventor
Felipa A Mapa
Kimberly Carr Ferguson
Arthur Brace
Donald Ruhrmund
Cynthia Seidel-Dugen
Agnes V Eliares
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of AU2003215004A1 publication Critical patent/AU2003215004A1/en
Publication of AU2003215004A8 publication Critical patent/AU2003215004A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003215004A 2002-02-06 2003-02-05 Msrebps as modifiers of the srebp pathway and methods of use Abandoned AU2003215004A1 (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US35468902P 2002-02-06 2002-02-06
US60/354,689 2002-02-06
US35812502P 2002-02-20 2002-02-20
US60/358,125 2002-02-20
US35876602P 2002-02-21 2002-02-21
US35878602P 2002-02-21 2002-02-21
US60/358,766 2002-02-21
US60/358,786 2002-02-21
US36045802P 2002-02-25 2002-02-25
US35939502P 2002-02-25 2002-02-25
US36040402P 2002-02-25 2002-02-25
US35941002P 2002-02-25 2002-02-25
US36030202P 2002-02-25 2002-02-25
US60/359,395 2002-02-25
US60/359,410 2002-02-25
US60/360,458 2002-02-25
US60/360,302 2002-02-25
US60/360,404 2002-02-25
US36035902P 2002-02-26 2002-02-26
US60/360,359 2002-02-26
PCT/US2003/003384 WO2003066811A2 (en) 2002-02-06 2003-02-05 Msrebps as modifiers of the srebp pathway and methods of use

Publications (2)

Publication Number Publication Date
AU2003215004A1 AU2003215004A1 (en) 2003-09-02
AU2003215004A8 true AU2003215004A8 (en) 2003-09-02

Family

ID=27739569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003215004A Abandoned AU2003215004A1 (en) 2002-02-06 2003-02-05 Msrebps as modifiers of the srebp pathway and methods of use

Country Status (2)

Country Link
AU (1) AU2003215004A1 (en)
WO (1) WO2003066811A2 (en)

Also Published As

Publication number Publication date
WO2003066811A3 (en) 2005-03-31
WO2003066811A2 (en) 2003-08-14
AU2003215004A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
AU2003213606A8 (en) Mp53s as modifiers of the p53 pathway and methods of use
EP1402058A4 (en) Dgks as modifiers of the p53 pathway and methods of use
EP1466175A4 (en) SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
EP1651956A4 (en) Melks as modifiers of the rac pathway and methods of use
EP1535067A4 (en) PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE
AU2003272400A8 (en) Syts as modifiers of the p21 pathway and methods of use
AU2003295881A8 (en) Lamps as modifiers of the p53 pathway and methods of use
AU2003251799A1 (en) Mchks as modifiers of the chk1 pathway and methods of use
AU2003215004A8 (en) Msrebps as modifiers of the srebp pathway and methods of use
AU2003303094A8 (en) Mat2as as modifiers of the p53 pathway and methods of use
AU2003274911A8 (en) Mrbs as modifiers of the rb pathway and methods of use
AU2003251826A8 (en) Mp21s as modifiers of the p21 pathway and methods of use
EP1534852A4 (en) CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003294499A8 (en) Rhebs as modifiers of the rb pathway and methods of use
AU2003213665A8 (en) Lgals as modifiers of the chk pathway and methods of use
AU2003213693A8 (en) Mchks as modifiers of the chk pathway and methods of use
HK1080110A1 (en) Paks as modifiers of the chk pathway and methods of use
AU2003299990A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003217851A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2002332130A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
AU2002361654A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
EP1578945A3 (en) Cct6s as modifiers of the rb pathway and methods of use
AU2003278811A8 (en) Ldlrs as modifiers of the p53 pathway and methods of use
AU2003213662A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003295928A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase